![Kenneth R. Chien](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kenneth R. Chien
Direktör/Styrelseledamot på
eTheRNA immunotherapies NV
Profil
Kenneth R.
Chien was the founder of Moderna, Inc. (2010), ModernaTX, Inc. (2011), and Celladon Corp.
(2000) where the title held was Director from 2009 to 2010.
Current jobs include Director at eTheRNA immunotherapies NV since 2022, Professor at Harvard University, Professor at Karolinska Institutet, and Member at Harvard Stem Cell Institute.
Former jobs include Scientific Director at The General Hospital Corp.
and Principal at the University of California San Diego.
Aktiva positioner av Kenneth R. Chien
| Företag | Position | Start |
|---|---|---|
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Företagsledare/Principal | - |
Harvard Stem Cell Institute
 Harvard Stem Cell Institute BiotechnologyHealth Technology Provides research regarding stem cells necessary for the understanding of human development and disease and trains next generation stem cell scientists | Företagsledare/Principal | - |
Karolinska Institutet
 Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Företagsledare/Principal | - |
eTheRNA immunotherapies NV
 eTheRNA immunotherapies NV BiotechnologyHealth Technology Develops novel immunotherapies to overcome cancers and infectious diseases | Direktör/Styrelseledamot | 2022-08-22 |
Tidigare kända positioner av Kenneth R. Chien
| Företag | Position | Slut |
|---|---|---|
| MODERNA, INC. | Grundare | - |
University of California San Diego
 University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Företagsledare/Principal | - |
The General Hospital Corp.
 The General Hospital Corp. Hospital/Nursing ManagementHealth Services Functions as a non profit organization that operates general hospital | Teknisk/Vetenskaplig/F&U Direktör | - |
ModernaTX, Inc.
 ModernaTX, Inc. BiotechnologyHealth Technology Develops messenger RNA therapeutics | Grundare | - |
Celladon Corp.
 Celladon Corp. BiotechnologyHealth Technology Develops molecular therapies for cardiovascular diseases | Grundare | - |
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
92
Första gradens relationer
9
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 9 |
|---|---|
Celladon Corp.
Celladon Corp. BiotechnologyHealth Technology Develops molecular therapies for cardiovascular diseases | Health Technology |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The General Hospital Corp.
The General Hospital Corp. Hospital/Nursing ManagementHealth Services Functions as a non profit organization that operates general hospital | Health Services |
Karolinska Institutet
Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California San Diego
University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Stem Cell Institute
Harvard Stem Cell Institute BiotechnologyHealth Technology Provides research regarding stem cells necessary for the understanding of human development and disease and trains next generation stem cell scientists | Health Technology |
ModernaTX, Inc.
ModernaTX, Inc. BiotechnologyHealth Technology Develops messenger RNA therapeutics | Health Technology |
eTheRNA immunotherapies NV
eTheRNA immunotherapies NV BiotechnologyHealth Technology Develops novel immunotherapies to overcome cancers and infectious diseases | Health Technology |
Moderna, Inc.
 Moderna, Inc. BiotechnologyHealth Technology Researches, develops, manufactures and commercializes mRNA-based respiratory & other virus vaccines, oncology and rare disease therapeutics | Health Technology |
